Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

Sphingosine-1-phosphate receptor modulators and anti-CD20 treatment are widely used disease-modifying treatments for multiple sclerosis. Unfortunately, they may impair the patient’s ability to mount sufficient humoral and T-cellular responses to vaccination, which is of special relevance in the cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Woopen, Christina, Konofalska, Urszula, Akgün, Katja, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360990/
https://www.ncbi.nlm.nih.gov/pubmed/35958567
http://dx.doi.org/10.3389/fimmu.2022.897748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360990/
https://www.ncbi.nlm.nih.gov/pubmed/35958567
http://dx.doi.org/10.3389/fimmu.2022.897748

Ejemplares similares